126
Participants
Start Date
March 6, 2025
Primary Completion Date
June 30, 2029
Study Completion Date
June 30, 2029
Tirzepatide
Titrated to dose of 5 mg once weekly subcutaneous
Placebo
Titrated to dose of 5 mg once weekly subcutaneous
RECRUITING
University of Colorado - Anschutz Medical Campus, Aurora
Collaborators (1)
Washington University School of Medicine
OTHER
Mayo Clinic
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Colorado, Denver
OTHER